PAS-004 Capsules
PAS-004-102
Phase 1 small_molecule active
Quick answer
PAS-004 Capsules for RAS Mutation is a Phase 1 program (small_molecule) at Pasithea Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pasithea Therapeutics
- Indication
- RAS Mutation
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active